Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using 90Y-NM600 in combination with androgen deprivation therapy in murine prostate tumors.
Muralidhar A, Hernandez R, Morris ZS, Comas Rojas H, Bio Idrissou M, Weichert JP, McNeel DG. Muralidhar A, et al. Among authors: mcneel dg. J Immunother Cancer. 2024 Apr 24;12(4):e008760. doi: 10.1136/jitc-2023-008760. J Immunother Cancer. 2024. PMID: 38663936 Free PMC article.
Toll-like receptor agonists as cancer vaccine adjuvants.
Jeon D, Hill E, McNeel DG. Jeon D, et al. Among authors: mcneel dg. Hum Vaccin Immunother. 2024 Dec 31;20(1):2297453. doi: 10.1080/21645515.2023.2297453. Epub 2023 Dec 28. Hum Vaccin Immunother. 2024. PMID: 38155525 Free PMC article. Review.
Strong Evidence for ^{9}N and the Limits of Existence of Atomic Nuclei.
Charity RJ, Wylie J, Wang SM, Webb TB, Brown KW, Cerizza G, Chajecki Z, Elson JM, Estee J, Hoff DEM, Kuvin SA, Lynch WG, Manfredi J, Michel N, McNeel DG, Morfouace P, Nazarewicz W, Pruitt CD, Santamaria C, Sweany S, Smith J, Sobotka LG, Tsang MB, Wuosmaa AH. Charity RJ, et al. Among authors: mcneel dg. Phys Rev Lett. 2023 Oct 27;131(17):172501. doi: 10.1103/PhysRevLett.131.172501. Phys Rev Lett. 2023. PMID: 37955509
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.
Leidner R, Conlon K, McNeel DG, Wang-Gillam A, Gupta S, Wesolowski R, Chaudhari M, Hassounah N, Lee JB, Ho Lee L, O'Keeffe JA, Lewis N, Pavlakis GN, Thompson JA. Leidner R, et al. Among authors: mcneel dg. J Immunother Cancer. 2023 Oct;11(10):e007725. doi: 10.1136/jitc-2023-007725. J Immunother Cancer. 2023. PMID: 37907221 Free PMC article. Clinical Trial.
155 results